Contract 75N93019P01250
Genscript USA Inc · Department Of Health And Human Services · July 5, 2024
Genscript USA Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 5, 2024 for $1.15 million (current value) of work in biological product (except diagnostic) manufacturing. Performance is in Piscataway, NJ. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $1.15 million.
Contract details
- PIID
- 75N93019P01250
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Piscataway, NJ
- First action
- July 5, 2024
Description
GENSCRIPT CUSTOMIZED BIOLOGICALS
Modification timeline
-
July 5, 2024Mod P00004 · Supplemental Agreement For Work Within Scope$1.15M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Jackson Laboratory | Department Of Health And Human Services | July 1, 2026 | $248.9K |
| Emergent Product Development Gaithersburg Inc. | Department Of Health And Human Services | June 26, 2026 | $857.64M |
| Banner Health | Department Of Health And Human Services | June 26, 2026 | $30.2K |
| Life Technologies Corporation | Department Of Health And Human Services | June 26, 2026 | $50.7K |
| Miltenyi Biotec, Inc. | Department Of Health And Human Services | June 25, 2026 | $4.57M |
| Miltenyi Biotec, Inc. | Department Of Health And Human Services | June 25, 2026 | $1.20M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Advanced Technology International | 10 | $225.00M |
| 2 | Sanofi Vaccines Us Inc. | 5 | $27.10M |
| 3 | Meridian Medical Technologies, Llc | 2 | $16.41M |
| 4 | American National Red Cross, The | 12 | $5.59M |
| 5 | Boehringer Ingelheim Animal Health USA Inc | 3 | $3.53M |
| 6 | Versiti Blood Health, Inc. | 12 | $2.52M |
| 7 | American National Red Cross, The | 1 | $1.93M |
| 8 | Miltenyi Biotec, Inc. | 3 | $1.50M |
| 9 | Artemis Technologies Inc | 2 | $983.6K |
| 10 | Oklahoma Blood Institute | 3 | $885.0K |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93019P01250?
Contract 75N93019P01250 is a federal contract awarded to Genscript USA Inc by Department Of Health And Human Services on July 5, 2024 for $1.15 million of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N93019P01250?
Genscript USA Inc won contract 75N93019P01250 from Department Of Health And Human Services.
How much is contract 75N93019P01250 worth?
Contract 75N93019P01250 has obligated $0 to date but carries a potential ceiling of $1.15 million if fully funded and all options are exercised.